title: Case of sorafenib-induced thyroid storm.
authors.affiliation: Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. Sigurdis.Haraldsdottir@osumc.edu
authors.forename: Sigurdis
authors.initials: S
authors.lastname: Haraldsdottir
authors.forename: Quan
authors.initials: Q
authors.lastname: Li
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Villalona-Calero
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Olencki
authors.forename: Kari
authors.initials: K
authors.lastname: Kendra
authors.forename: Steven W
authors.initials: SW
authors.lastname: Ing
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000188:drug therapy / Q000556:secondary; D000368:Aged; D000638:Amiodarone / Q000008:administration & dosage; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D015415:Biomarkers / Q000097:blood; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006323:Heart Arrest / Q000209:etiology; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D019042:Muscle Neoplasms / Q000188:drug therapy / Q000556:secondary; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D053120:Respiratory Aspiration / Q000150:complications; D000077157:Sorafenib; D013958:Thyroid Crisis / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D013963:Thyroid Hormones / Q000097:blood*
chemical_list: D000889:Anti-Arrhythmia Agents; D000970:Antineoplastic Agents; D015415:Biomarkers; D010671:Phenylurea Compounds; D047428:Protein Kinase Inhibitors; D013963:Thyroid Hormones; D009536:Niacinamide; D000077157:Sorafenib; D011505:Protein-Tyrosine Kinases; D000638:Amiodarone